Sir Chris Hoy, six-time Olympic champion, has shared his terminal diagnosis of #ProstateCancer with a powerful message: initiate early screening for men with a strong family history. “Catch it before they need major treatment,” he urges to lower the age of detection to save lives. This call comes at an opportune time, as the largest prostate cancer screening trial in 20 years, the TRANSFORM trial, is underway in the UK. This initiative is an ambitious effort to determine the most effective #screening methods and offers a critical opportunity to reshape early detection. ➡️ https://lnkd.in/dQxJV5vu
October is always a key month. Here are some of the highlights that we shared these last weeks: 🌐 The launch of our website in Spanish and French! 🩷 Breast Cancer Awareness Month: the MASAI trial has recently proven that AI can cut radiologists' workload by 44% 💡 QP-Prostate helps radiologists detect over 90% of prostate cancer cases in Spain Stay up to date on #AI, #Radiomics, and #CancerCare in our newsletter - subscribe now!
Many of you have asked how to help the victims of the severe storms and flooding these days in Valencia. Here’s a list of organizations and associations actively providing assistance on the ground:
Next November 13, we will be at the annual Personalized Medicine Coalition conference in Boston, and our CEO, Dr. Ángel Alberich-Bayarri will participate in the session "Transforming Standard-of-Care Imaging into Precision Diagnostics" together with Chiranjiv Singh, Okan Ekinci, MD MBA and Megan Nacar. If you’re around, swing by Room 217 at 12:30 PM and join us for an engaging debate. We’d love to see you there! Check out the full program at https://lnkd.in/dzB6E7mM
Our heartfelt support goes out to all those affected by the heavy rains and flash floods in the Valencian Community, home to Quibim. Todo nuestro apoyo a los afectados y las víctimas de la DANA en su paso por la Comunidad Valenciana, nuestra casa.
🇨🇵 Et nous voilà aussi plus proches des professionnels de santé en France grâce au lancement de notre site web entièrement en français. Rendez-nous visite sur www.quibim.com/fr pour découvrir Quibim et réserver une démo en français!
¡Ya estamos en vivo! Desde hoy la web de Quibim también en español 🌎 https://quibim.com/es/ Nos enorgullece enormemente compartir el lanzamiento de nuestra página web en el idioma de millones de profesionales de la salud en todo el mundo. Visítanos y descubre Quibim en español. ¡Bienvenidos!
Shortly after a month of attending #ESMO24, we are back in Barcelona for the 36th edition of EORTC - European Organisation for Research and Treatment of Cancer, National Cancer Institute (NCI), and American Association for Cancer Research (ENA 2024) Symposium ⭐ A unique occasion to get ahold of the latest scientific advancements in precision medicine, drug development, and cancer care. #PrecisionMedicine #CancerCare #healthcareInnovation
Yesterday we played at home!📍 We had the privilege of participating in the 7th edition of VDS, contributing to two insightful roundtables: “It's Happening Now: Real-World Examples Showcasing the Healthcare Transformation”, with our CEO, Dr. Ángel Alberich-Bayarri, and “AI Revolution: Shaping Supply Chain and Entertainment. Insights into Technological and Investment Strategies” with Quibim's VP of AI, Ana Jimenez Pastor. A big thank you to everyone who joined us in these discussions, and to the event organizers for inviting Quibim for another year. #VDS continues to be an exceptional platform to gather new insights, discuss current and future ideas, and connect with leading professionals. #PrecisionMedicine #AIInHealthcare #VDS24
Today, our Clinical Project Manager Alejandra Estepa Fernández, PhD, presented at the European Association of Nuclear Medicine (EANM) 2024 our poster "Imaging Features and Clinical Data-Based Network Analysis of CAR-T Treated B-Cell Lymphoma Patients in Relation to Their TP53 Mutation Status", where the use of QP-Insights was key. Check out her post to know more!
